Under the agreement, Syngenta will evaluate KOMO’s non-viral, integrase-based genome engineering technology for research applications focused on the controlled and predictable introduction of genetic ...
Real Science on MSN
Watch scientists try to bring an extinct animal back to life
What if extinction wasn’t the end? Scientists are exploring new technologies that could potentially bring extinct animals back to life. By studying ancient DNA and using advanced genetic engineering ...
Cas9, Transcription Activator-Like Effector Nucleases (TALENs), and Zinc-Finger nucleases (ZFNs) have demonstrated great utility, primarily for genetic knock-out applications, none have been adopted ...
A modified orange rootstock is the latest advance in fighting citrus greening disease, a Florida company told the federal ...
Stephen Hawking's black hole fame wasn't his only focus — he also laid out multiple existential threats. Here are five doomsday risks he talked about.
Chimeric antigen receptor T (CAR T) cell therapy represents a milestone in leukemia treatment. CAR T works by genetically engineering a chimeric antigen receptor on the surface of the patient's T ...
FACE binds to CD71 on the T‑cell surface in CAR T cell preparation, and post-infusion, the same FACE molecules attach to CD71 on leukemia cells.
Real Science on MSN
Genetic modification is just changing DNA – and DNA controls life and death
Genetically modified organisms have been at the center of controversy for decades. But what does the science actually say? Modern genetic engineering allows scientists to introduce specific traits ...
News-Medical.Net on MSN
Biomimetic platform enhances CAR T therapy for relapsed and refractory leukemia
Chimeric antigen receptor T (CAR T) cell therapy represents a milestone in leukemia treatment. CAR T works by genetically engineering a chimeric antigen receptor on the surface of the patient's T ...
The request to extend deregulation, APHIS’ preliminary decision, and PPRSA will be available for public review and comment for 30 days beginning March 6, 2026. Members of the public can submit ...
Results demonstrated early signals of C-peptide preservationT1D key opinion leader, Michael J. Haller, MD, provided a recorded webinar reviewing ...
A researcher's keen eye and spirit of curiosity led to the discovery of a new method for cell engineering - a finding that opens doors to more ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results